EVERYTHING ABOUT HEMGENIX

Number of eligible patients: CDEC mentioned the uncertainty in the amount of individuals with reasonably serious to significant hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some sufferers who will be classified as getting moderate or reasonable ailment may have a extreme ble